12 April 2019
Message from the Chair
The Board of Directors of the BioMelbourne Network is pleased to announce the appointment of Dr Julie-Anne White as our new Chief Executive Officer, effective 13 May.
Julie holds a BSc. Pharmacology from the University of Adelaide, MSc. Neuroscience from Kings College, University of London and PhD in Psychopharmacology from the Institute of Psychiatry, Kings College, University of London, England.
Julie has a broad base of scientific knowledge, both diverse and deep, with significant translational research and commercialisation experience within the biotech and pharma sector. She has a significant range of diverse business and leadership experience from start-ups to large pharma within different geographic jurisdictions, therapeutic areas, manufacturing, R&D and commercialisation.
Julie has held the role of CEO/MD in several organisations including private and publicly listed companies and co-operative research centres. Most recently, she has acted as Deloitte Private Business Advisor for the Federal Government Entrepreneurs Program in the medtech/pharma/biotech growth sector. Her portfolio for the Federal Government included nearly 50 biotech/medtech Companies in Victoria, South Australia, Tasmania and Queensland. In this role she advised SMEs and industry bodies about government policies and strategy, acting as an interface between industry and government for the medtech pharma sector. Additionally, Julie has worked for over a decade in Europe in the large pharma/biotech sector with roles in Wyeth Pharmaceuticals, Merck, Sharpe and Dohme and Cerebrus.
Other key roles have been as CEO of Avipep and Deputy CEO of the CRC for Polymers. She also has experience as CEO of start-up companies Salus Technologies Ltd and Zingo TX Pty Ltd.
This broad and diverse experience in science, research and development, commercialisation, education and business environment, ideally places Julie to take the BioMelbourne Network forward in the next phase of our strategic development in order to serve the needs of our members even more effectively.
We look forward to warmly welcoming Julie in May and introducing her to members and key stakeholders.
Chair BioMelbourne Network